
Letybo®: A New FDA-Approved Neurotoxin for Glabellar Lines
Letybo® received FDA approval on February 29, 2024, for the temporary improvement of moderate to severe glabellar lines in adult patients. With its high purity, precise diffusion pattern, and impressive clinical results, Letybo® offers medical providers a valuable new option in aesthetic medicine.